Bajaj Healthcare enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


1,059	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
13.5	37.2	2.6	2.2	17.7
233	233	223	332	414
1,279	—	—	—	—
220	196	220	330	397
₹379.80	—	—	—	—

791	766	689	610	782
29.5%	30.5%	32.3%	54.4%	53.0%
0.18×	—	—	—	—

1.95×	—	—	—	—
11.28×	—	—	—	—
15.25×	—	—	—	—
86.79×	—	—	—	—
656	611	543	473	673
113	105	82.4	76.3	107
83.8	77.3	54.5	48.6	79.5
—	58.1	21.6	92.3	−22.3
14.7	14.7	10.1	62.0	−116
—	9.2	8.2	56.1	−122
—	43.3	11.5	30.3	93.6

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

BAJAJHCARE₹314.45

Bajaj Healthcare Limited

· Pharma & Health

₹ CrorePeersTHEMISMED LINCOLN WANBURY SIGACHI AHCL ANUHPHR AMRUTANJANMcap ₹1,059 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	1,058.5
- Cash, Equiv & ST Investments	17.7	2.2	2.6	37.2	13.5
+ Total Debt	414.3	332.1	222.6	233.5	233.5
Enterprise Value	—	—	—	—	1,278.5
Net Debt (memo)	396.6	329.9	220.0	196.2	220.0
EV per Share	—	—	—	—	379.80

Total Capital	782.0	610.4	688.8	766.5	790.6
Total Debt/Total Capital	52.98	54.40	32.32	30.46	29.53
Total Debt/EV	—	—	—	—	0.18

EV/Sales	—	—	—	—	1.95
EV/EBITDA	—	—	—	—	11.28
EV/EBIT	—	—	—	—	15.25
EV/Free Cash Flow	—	—	—	—	86.79
Reference Items — Trailing FY Values
Sales	673.3	473.4	542.6	611.0	655.8
EBITDA	106.8	76.3	82.4	104.8	113.3
EBIT	79.5	48.6	54.5	77.3	83.8
Operating Cash Flow	-22.3	92.3	21.6	58.1	—
Free Cash Flow	-115.9	62.0	10.1	14.7	14.7
FCFF (free cash flow to the firm)	-121.9	56.1	8.2	9.2	—
Capital Expenditure	93.6	30.3	11.5	43.3	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.